Catalyst Pharmaceuticals Inc (CPRX)
21.25
+0.13
(+0.62%)
USD |
NASDAQ |
Nov 22, 09:30
Catalyst Pharmaceuticals Shareholders Equity (Quarterly): 660.94M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 660.94M |
June 30, 2024 | 608.66M |
March 31, 2024 | 561.41M |
December 31, 2023 | 387.88M |
September 30, 2023 | 348.55M |
June 30, 2023 | 375.29M |
March 31, 2023 | 333.66M |
December 31, 2022 | 300.42M |
September 30, 2022 | 270.04M |
June 30, 2022 | 241.09M |
March 31, 2022 | 220.22M |
December 31, 2021 | 206.83M |
September 30, 2021 | 198.66M |
June 30, 2021 | 188.94M |
March 31, 2021 | 178.65M |
December 31, 2020 | 169.60M |
September 30, 2020 | 156.63M |
June 30, 2020 | 111.20M |
March 31, 2020 | 99.68M |
December 31, 2019 | 87.63M |
September 30, 2019 | 77.98M |
June 30, 2019 | 63.28M |
March 31, 2019 | 51.18M |
December 31, 2018 | 50.78M |
September 30, 2018 | 64.08M |
Date | Value |
---|---|
June 30, 2018 | 71.06M |
March 31, 2018 | 76.25M |
December 31, 2017 | 80.96M |
September 30, 2017 | 31.73M |
June 30, 2017 | 33.97M |
March 31, 2017 | 35.10M |
December 31, 2016 | 39.31M |
September 30, 2016 | 42.90M |
June 30, 2016 | 46.33M |
March 31, 2016 | 50.54M |
December 31, 2015 | 55.48M |
September 30, 2015 | 60.65M |
June 30, 2015 | 62.79M |
March 31, 2015 | 66.62M |
December 31, 2014 | 35.24M |
September 30, 2014 | 36.62M |
June 30, 2014 | 41.19M |
March 31, 2014 | 17.64M |
December 31, 2013 | 21.39M |
September 30, 2013 | 22.12M |
June 30, 2013 | 9.844M |
March 31, 2013 | 12.92M |
December 31, 2012 | 14.62M |
September 30, 2012 | 9.395M |
June 30, 2012 | 6.411M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
87.63M
Minimum
Dec 2019
660.94M
Maximum
Sep 2024
285.30M
Average
230.66M
Median
Shareholders Equity (Quarterly) Benchmarks
Corcept Therapeutics Inc | 638.84M |
Vertex Pharmaceuticals Inc | 15.63B |
Sarepta Therapeutics Inc | 1.221B |
ADMA Biologics Inc | 231.89M |
BioVie Inc | 14.07M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 772.01M |
Total Liabilities (Quarterly) | 111.07M |
Current Ratio | 5.114 |